236 related articles for article (PubMed ID: 31849838)
1. Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis.
Liu Y; Ma L; Yang X; Bie J; Li D; Sun C; Zhang J; Meng Y; Lin J
Front Endocrinol (Lausanne); 2019; 10():801. PubMed ID: 31849838
[No Abstract] [Full Text] [Related]
2. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.
Li D; Ding CY; Qiu LH
Gynecol Oncol; 2015 Nov; 139(2):355-62. PubMed ID: 26232517
[TBL] [Abstract][Full Text] [Related]
3. The association between different hormone replacement therapy use and the incidence of lung cancer: a systematic review and meta-analysis.
Wen H; Lin X; Sun D
J Thorac Dis; 2022 Feb; 14(2):381-395. PubMed ID: 35280481
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and ovarian cancer risk: a meta-analysis.
Zhou B; Sun Q; Cong R; Gu H; Tang N; Yang L; Wang B
Gynecol Oncol; 2008 Mar; 108(3):641-51. PubMed ID: 18221779
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy and risk of ovarian cancer in postmenopausal women: a systematic review and meta-analysis.
Shi LF; Wu Y; Li CY
Menopause; 2016 Apr; 23(4):417-24. PubMed ID: 26506499
[TBL] [Abstract][Full Text] [Related]
6. The Relationship Between Hormone Replacement Therapy and Risk of Kidney Cancer in Women: A Meta-Analysis.
Zhang X; Du Y; Tan X; Wang H; Li Y; Zhang Z; Wang A
Cancer Control; 2020; 27(2):1073274820930194. PubMed ID: 32668959
[TBL] [Abstract][Full Text] [Related]
7. Dietary fat intake and ovarian cancer risk: a meta-analysis of epidemiological studies.
Qiu W; Lu H; Qi Y; Wang X
Oncotarget; 2016 Jun; 7(24):37390-37406. PubMed ID: 27119509
[TBL] [Abstract][Full Text] [Related]
8. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies.
Kim S; Ko Y; Lee HJ; Lim JE
Breast Cancer Res Treat; 2018 Aug; 170(3):667-675. PubMed ID: 29713854
[TBL] [Abstract][Full Text] [Related]
10. Age at last birth and risk of developing epithelial ovarian cancer: a meta-analysis.
Wu Y; Sun W; Xin X; Wang W; Zhang D
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31471530
[No Abstract] [Full Text] [Related]
11. Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study.
Hempling RE; Wong C; Piver MS; Natarajan N; Mettlin CJ
Obstet Gynecol; 1997 Jun; 89(6):1012-6. PubMed ID: 9170483
[TBL] [Abstract][Full Text] [Related]
12. Calcium Intake and the Risk of Ovarian Cancer: A Meta-Analysis.
Song X; Li Z; Ji X; Zhang D
Nutrients; 2017 Jun; 9(7):. PubMed ID: 28665326
[TBL] [Abstract][Full Text] [Related]
13. Alcohol drinking and epithelial ovarian cancer risk. a systematic review and meta-analysis.
Rota M; Pasquali E; Scotti L; Pelucchi C; Tramacere I; Islami F; Negri E; Boffetta P; Bellocco R; Corrao G; La Vecchia C; Bagnardi V
Gynecol Oncol; 2012 Jun; 125(3):758-63. PubMed ID: 22449732
[TBL] [Abstract][Full Text] [Related]
14. Association Between Benign Ovarian Tumors and Ovarian Cancer Risk: A Meta-Analysis of Ten Epidemiological Studies.
Guo J; Feng H; Gu X
Front Oncol; 2022; 12():895618. PubMed ID: 35646702
[TBL] [Abstract][Full Text] [Related]
15. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract][Full Text] [Related]
16. Association of hormone replacement therapy with risk of gastric cancer: a systematic review and meta-analysis.
Jang YC; Leung CY; Huang HL
Sci Rep; 2022 Jul; 12(1):12997. PubMed ID: 35906381
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
18. Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies.
Negri E; Tzonou A; Beral V; Lagiou P; Trichopoulos D; Parazzini F; Franceschi S; Booth M; La Vecchia C
Int J Cancer; 1999 Mar; 80(6):848-51. PubMed ID: 10074916
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and Parkinson's disease risk in women: a meta-analysis of 14 observational studies.
Wang P; Li J; Qiu S; Wen H; Du J
Neuropsychiatr Dis Treat; 2015; 11():59-66. PubMed ID: 25657580
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
